MSTN, Human (Stamulumab biosimilar) Antibody from KMD BIOSCIENCE CO. LTD.

Search, find, compare suppliers for anti-MSTN, Human (Stamulumab biosimilar) antibody, protein, ELISA kits.

Edit 
Antigenic SpecificityMSTN, Human (Stamulumab biosimilar)
CloneStamulumab
Host SpeciesRecombinant Mouse
Reactive Specieshuman
IsotypeIgG1
Formatpurified
Size1mg, 5mg
Concentration1mg/ml
ApplicationsFuncS, IF, Neut, ELISA, FCM, IP, ICC
Reviews / RatingsIf you have used this antibody, please help fellow researchers by submitting reviews to pAbmAbs and antYbuddY.
DescriptionAnti-Human MSTN Recombinant Antibody (Stamulumab). Stamulumab (MYO-029) is an experimental myostatin inhibiting drug developed by Wyeth Pharmaceuticals for the treatment of muscular dystrophy (MD). Stamulumab was formulated and tested by Wyeth in Collegeville, Pennsylvania.
Immunogenn/a
Other NamesAnti-MSTN Recombinant Antibody, Research Grade Stamulumab, Anti-Human MSTN Recombinant Antibody(Stamulumab), MYO-029, Antibody Drug Analogues, Monoclonal Antibody, YR1127, Research Grade Biosimilars, Biosimilar Antibody
Gene, Accession #CAS: 705287-60-1
Catalog #YR1127
Priceplease inquire
Order / More InfoMSTN, Human (Stamulumab biosimilar) Antibody from KMD BIOSCIENCE CO. LTD.
Product Specific Referencesn/a
KMD BIOSCIENCE CO. LTD.
KMD BIOSCIENCE CO. LTD.
KMD BIOSCIENCE CO. LTD.
FL-4, Building A5
International Enterprise Community
Tianjin CHINA
P: 400-621-6806

info@kmdbioscience.com
Sales: sales@kmdbiosci.com

https://www.kmdbioscience.com

Profile of KMD BIOSCIENCE CO. LTD.
Return to Antibodies

© 1980 - 2024 Linscott's Directory, Linscott's USA. All rights reserved.